CAS: 91618-36-9; Ibafloxacine

该化合物是合成的氟己酮抗生素,其特点是其广泛频谱抗菌活性,主要用于治疗各种细菌感染,特别是由克-阴性有机体和某些克-阳性有机体造成的感染;该复合物展示了一种行动机制,它抑制了细菌DNA gyras 和Topa异构体IV, 一种对DNA复制和转录至关重要的酶.Ibafloxain因其有利的药用植物性能而闻名,包括口服生物利用率和组织渗透,这提高了治疗效果.该物质通常作为白色的脱白晶粉和脱白晶粉,在有机溶剂中溶解,但水溶解有限.其化学结构包括一种含有氟子原子的双环核,这助长了其对细菌过量机制的腐蚀性和抗性.与其他氟丙酮一样,对于潜在的副作用,包括流行性脑炎和对家畜发育的影响,特别是在石化组群中,建议谨慎.

结构式图片

上下游产品

Ethyl 6,7-Dihydro-5,8-Dimethyl-9-Fluoro-1-Oxo-1H,5H-Benzo[i,J]Quinolizine-2-Carboxylate 91651-48-8

合成工艺路线路线简述

    📜Ethyl 6,7-Dihydro-5,8-Dimethyl-9-Fluoro-1-Oxo-1H,5H-Benzo[i,J]Quinolizine-2-Carboxylate 反应生成 依巴沙星
    参考文献:Process For
    标题:Process For
    摘要:一种制备抗微生物药物6,7-二氢-9-氟-5,8-二甲基-1-氧代-1H,5H-苯并[i,J]喹啉-2-羧酸的工艺,以6-氟-2-甲基喹啉为起始物质.还公开了一种合成中间体.

    海关参考信息

    专利信息


    专利号:US-11332444-B2
    优先权日:2018-04-25
    标题:Method for the hydrolysis of quinolonecarboxylic esters
    发明人:FEY PETER; BERWE MATHIAS; WIRTHS Joerg; WISCHNAT RALF; LONGERICH MARKUS; DIETZEL ANTJE
    权利人:BAYER ANIMAL HEALTH GMBH
    摘要:Quinolonecarboxylic esters of the general formula (II) are hydrolyzed to quinolonecarboxylic acids of the general formula (I):The method comprises the step A):A) reacting compounds of the formula (II) with a mixture comprising acetic acid, sulfuric acid and waterIn step A), ≥30 to ≤40 mol of acetic acid, ≥0.3 to ≤1 mol of sulfuric acid and ≥0.9 to ≤2.5 mol of water are used per mole of compounds of the formula (II). The method is particularly suitable for the synthesis of the intermediate (I) in the synthesis of pradofloxacin.

    专利号:US-9693999-B2
    优先权日:2011-01-26
    标题:Small molecule RNase inhibitors and methods of use
    发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
    权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
    摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

    专利号:WO-2009056955-A1
    优先权日:2007-10-30
    标题 :Amine-bearing phospholipids (abps), their synthesis and use
    发明人:ZUMBUEHL ANDREAS
    权利人:UNIV BASEL; ZUMBUEHL ANDREAS
    摘要:Disclosed herein are amine-bearing phospholipids (ABP). The ABPs display many properties and functionalities of naturally occurring phospholipids, but also new properties and functionalities, such as the ability to polymerize while maintaining structural integrity, that may supplement or expand the functionalities of naturally occurring phospholipids.

    专利号:US-9868747-B2
    优先权日:2014-02-18
    标题:Marinopyrrole derivatives and methods of making and using same
    发明人:LI RONGSHI; SEBTI SAID; LIU YAN; QIN YONG; SONG HAO; CHENG CHUNWEI
    权利人:H LEE MOFFITT CANCER CT & RES; CHONGQING ZEIN PHARMACEUTICAL CO LTD
    摘要:Marinopyrrole derivatives and methods for their synthesis and use are described herein. Novel cyclic and symmetric marinopyrroles with triazole substituents having antibacterial activity against resistant bacterial strains, such as MRSA are introduced. Also provided are methods of using the compounds for treating or preventing cancer and/or microbial infections.

    专利号:US-9907753-B2
    优先权日:2010-03-19
    标 题 :Lipid vesicle compositions and methods of use
    发明人:IRVINE DARRELL J; MOON JAEHYUN
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.

    专利号:JP-H07300461-A
    优先权日:1986-01-22
    标题 :Intermediate for synthesis of 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H, 5H-benzo [i, j] quinolizine-2-carboxylic acid and process for producing the same

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    1. Horspool LJ, van Laar P, van den Bos R, Mawhinney I. Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles. J Vet Pharmacol Ther. 2004 Jun;27(3):147-53. doi: 10.1111/j.1365-2885.2004.00561.x. 158(7):236-7. doi: 10.1136/vr.158.7.236.

    合成参考文献


    参考文献:10.1046/j.1365-2885.2002.00361.x
    摘要:Coulet M, Van Borssum Waalkes M, Leeuwenkamp OR, Cox P, Lohuis J. Pharmacokinetics of ibafloxacin following intravenous and oral administration to healthy Beagle dogs. J Vet Pharmacol Ther. 2002 Apr;25(2):89–97. doi: 10.1046/j.1365-2885.2002.00361.x.
    参考文献:10.1111/j.1365-2885.2004.00561.x
    摘要:Horspool LJ, van Laar P, van den Bos R, Mawhinney I. Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles. J Vet Pharmacol Ther. 2004 Jun;27(3):147–53. doi: 10.1111/j.1365-2885.2004.00561.x.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知